Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Axogen (NASDAQ:AXGN) and maintained a $16 price target.
September 26, 2023 | 3:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axogen's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $16.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Axogen. The maintained price target of $16 also suggests that the analyst believes the stock is undervalued at current levels. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100